Your session is about to expire
← Back to Search
Biospecimen Analysis for Lung Cancer
Study Summary
This trial is investigating how well different types of biospecimens can be used to screen for and manage lung cancer, with the goal of developing precision medicine. A co-clinical trial approach will be used, meaning data from the treatment of genetic mouse models of lung cancer will be compared with clinical samples and data from lung cancer patients.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have recently coughed up blood.I do not have diabetes, heart disease, autoimmune disorders, or hepatitis.I have had part of my lung removed, but not just by needle biopsy.I have lost more than 15 pounds in the last year without trying.My lung cancer is scheduled for surgical removal.I have no significant cognitive impairments that would prevent me from fully participating.I am 18 years old or older.I have a chronic inflammatory condition like Lupus or Rheumatoid arthritis.My cancer cannot be removed by surgery and has spread.I have never smoked or I quit smoking in the last six months.I have been cancer-free for 5 years or my only past cancers were non-invasive.I have smoked at least 30 pack-years.You must be able to do intense exercise for 30 minutes and be able to tell us about it.I have Hepatitis C, Rheumatoid Arthritis, or have had an organ transplant.My doctor has approved me for standard or experimental cancer treatments.I haven't taken steroids in the last 3 months.You have smoked an average of at least one pack of cigarettes per day for 10 years or more.I have had lung cancer in the past.I have cancer and will be treated with radiation.I had a chest CT scan that showed possible cancer within the last 18 months.I am between 45 and 74 years old.I have been treated for pneumonia or a lung infection with antibiotics in the last 3 months.
- Group 1: Lung cancer with planned resection
- Group 2: At risk for lung cancer
- Group 3: Healthy people who exercise
- Group 4: Solid tumor cancer w/ radiation therapy
- Group 5: Lung/ Head and Neck Cancer Group
- Group 6: Chronic inflammatory disease
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the total sample size of participants for this experiment?
"Affirmative. The information published on clinicaltrials.gov confirms that this investigation is presently accepting participants; it was initially advertised on January 1st 2016 and the most recent update to its details occurred October 26th 2022. A total of 330 individuals are being sought at a single location for inclusion in the study."
What are the requirements for participating in this research study?
"This clinical trial seeks 330 individuals between 18 and 99 years old who are currently or formerly smokers with a minimum of 10 pack year smoking history, have been diagnosed with an inoperable metastatic lung cancer, head and neck cancer, or another form of solid tumor malignancy. In addition to meeting these prerequisites, prospective participants must sign a UAMS IRB-approved informed consent prior to being accepted into cohort A (Lung/Head and Neck Cancer Group)."
Is it permissible for individuals over 45 to partake in this investigation?
"This clinical trial is open to participants who are aged 18 or above, but not exceeding 99 years old."
Is it possible to enroll in this investigation now?
"Affirmative. Clinicaltrials.gov's records indicate that the search for trial participants is ongoing, as it was initially posted on January 1st 2016 and last updated October 26th 2022. There are 330 positions to fill at a single medical facility involved in this project."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger